CN101843703B - Chinese medicament for treating liver cirrhosis - Google Patents
Chinese medicament for treating liver cirrhosis Download PDFInfo
- Publication number
- CN101843703B CN101843703B CN2009102354989A CN200910235498A CN101843703B CN 101843703 B CN101843703 B CN 101843703B CN 2009102354989 A CN2009102354989 A CN 2009102354989A CN 200910235498 A CN200910235498 A CN 200910235498A CN 101843703 B CN101843703 B CN 101843703B
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- chinese
- liver cirrhosis
- root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
The invention relates to a Chinese medicament for treating liver cirrhosis, and belongs to the field of Chinese medicaments for treating digestive system diseases. The invention aims to provide the Chinese medicament with good effect and quick response. The Chinese medicament is prepared from the following raw materials: root of red-rooted salvia, root of rehmannia, radix pseudo-ginseng, India madder root, lucid ganoderma, Chinese angelica and the like. The Chinese medicament has the effects of strengthening body resistance and banking up root, tonifying qi and nourishing blood, activating blood and dissolving stasis, fostering yin and nourishing liver and softening hardness to dissipate stagnation, and has the advantages of obvious effect, exact medicinal effect and quick response.
Description
Technical field
The invention belongs to the field of Chinese medicines of treatment digestive system disease.
Background technology
The Chinese medicine that is used for the treatment of liver cirrhosis at present, the deficiency that has two aspects: the one, effect is obvious inadequately, the 2nd, it is slower to take effect, so that large quantities of liver cirrhosis patient constantly increases the weight of because of the fibrosis of liver, causes complication such as digestive tract hemorrhage, hepatic encephalopathy at last and death.Patient and family members thereof are dissatisfied to this.
At problem set forth above, the invention provides a kind of Chinese medicine for the treatment of liver cirrhosis, it is obvious inadequately that it can solve in this type of treatment by Chinese herbs in the past effect, the slower problem that takes effect, effective, instant effect, it is remarkable to have effect, drug effect is definite, the advantage of quick result.
Summary of the invention
The present invention is achieved through the following technical solutions:
1, a kind of Chinese medicine for the treatment of liver cirrhosis adopts the raw material of Chinese medicine preparation, and filling a prescription is (by weight):
Radix Salviae Miltiorrhizae 4-30 part Radix Rehmanniae 4-30 part Radix Notoginseng 3-20 part
Radix Rubiae 4-30 part Ganoderma 2-15 part Radix Angelicae Sinensis 3-25 part
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Radix Salviae Miltiorrhizae, the Radix Rehmanniae, Radix Rubiae, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; As required, can be made into Chinese medicine electuary, granule, powder, capsule, watered pill, tablets and other formulations.
The present invention is according to the folk tradition prescription, and the theory according to traditional Chinese medical science the body resistance strengthening and constitution consolidating, blood circulation promoting and blood stasis dispelling develops meticulously.Medical practice proves, liver cirrhosis is many because of the chronic hepatitis protracted course of disease, shows effect repeatedly and causes widely hepatic necrosis, large tracts of land hepatic fibrosis and cause that wherein hypoimmunity is a key factor.We Ganoderma, Radix Rehmanniae the body resistance strengthening and constitution consolidating, benefiting QI and nourishing blood, liver and kidney tonifying, enhancing human body immunity power; Radix Angelicae Sinensis, Radix Salviae Miltiorrhizae, Radix Rubiae, pseudo-ginseng blood-circulation-invigovating blood stasis dispelling, hard masses softening and resolving.All medicine compatibilities bring out the best in each other, and play the body resistance strengthening and constitution consolidating altogether, benefiting QI and nourishing blood, and blood circulation promoting and blood stasis dispelling, the nourishing YIN nourishing the liver, the merit of hard masses softening and resolving, effective, instant effect, it is remarkable to have effect, and drug effect is definite, the advantage of quick result.
The specific embodiment
By following embodiment the present invention is done and to specify:
1, get following prescription (weight is unit by gram):
The Radix Salviae Miltiorrhizae 60 gram Radix Rehmanniae 60 gram Radix Notoginseng 40 grams
Radix Rubiae 60 kairine sesames 30 gram Radix Angelicae Sinensis 60 grams
Weight in accordance with regulations, with conventional water extraction process Radix Salviae Miltiorrhizae, the Radix Rehmanniae, Radix Rubiae, Radix Angelicae Sinensis are extracted, make extractum fine powder 72 grams, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder, make fine particle, the capsule of packing into No. 0 is made 507 of Chinese medicinal capsules, and every capsules includes Chinese medicine fine powder and extract 0.28 gram.
2, get following prescription (weight is unit by gram):
The Radix Salviae Miltiorrhizae 200 gram Radix Rehmanniae 180 grams 7 120 grams
Radix Rubiae 200 kairine sesames 90 gram Radix Angelicae Sinensis 180 grams
By above-mentioned same method, make 1564 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
3, get following prescription (weight is unit by gram):
The Radix Salviae Miltiorrhizae 300 gram Radix Rehmanniae 300 gram Radix Notoginseng 200 grams
Radix Rubiae 300 kairine sesames 150 gram Radix Angelicae Sinensis 300 grams
By above-mentioned same method, make 2536 of Chinese medicinal capsules, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
4, get following prescription (by weight):
6 parts of 8 portions of Radix Notoginseng of 9 parts of Radix Rehmanniae of Radix Salviae Miltiorrhizae
8 parts of 5 parts of Radix Angelicae Sinensis of 9 portions of Ganodermas of Radix Rubiae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
5, get following prescription (by weight):
12 parts of 20 portions of Radix Notoginseng of 25 parts of Radix Rehmanniae of Radix Salviae Miltiorrhizae
20 parts of 12 parts of Radix Angelicae Sinensis of 25 portions of Ganodermas of Radix Rubiae
By above-mentioned same method, make Chinese medicinal capsule, every capsules includes Chinese medicine fine powder and extract 0.28 gram.
Clinical data:
The present invention is an example with traditional Chinese medical science liver cirrhosis, through 19 routine clinical observations.Selecting the tcm diagnosis liver cirrhosis is standard: limb is soft weak, and is weak from head to foot; Abdominal distention, nauseating, upper abdomen dull pain; Hepatomegaly, quality are hard partially; Jaundice, anemia or bleeding tendency is arranged; Liver palm, spider angioma, cutaneous pigmentation and edema etc. appear.As above symptom can be made a definite diagnosis.In making a definite diagnosis the object of observation, male's 11 examples, women's 8 examples do not have other serious disease, and the age is 51 years old-76 years old, 63.2 years old mean age.
Efficacy determination:
1, produce effects: weak disappearance, limbs are strong; Abdominal distention, feel sick, upper abdomen dull pain obviously alleviates; Anemia and hepatic face are obviously alleviated, and face is pale, occur ruddy; Edema disappears; Hepatic fibrosis inspection index is obviously alleviated.
2, effective: on one's body energetically; Abdominal distention, feel sick, vomiting, anemia, edema etc. alleviate to some extent.
3, invalid: the disease no change.
During clinical experiment, withdraw other medicines and health nutrient.Taking Chinese medicinal capsule of the present invention, observed 3 months, is a course of treatment.Instructions of taking: every day 3 times, each 5 capsules, every capsules include Chinese medicine fine powder and extract 0.28 gram, warm water delivery service after meal, symptom promptly has alleviation after 1 month, take 3 months after, symptom is obviously improved.19 philtrums of clinical experiment, produce effects 10 people, effective 8 people, invalid 1 people, total effective rate 94.7%.
Claims (1)
1. a Chinese medicine for the treatment of liver cirrhosis is characterized in that, described Chinese medicine is to adopt the raw material of Chinese medicine preparation, and the weight proportion of raw material of Chinese medicine is:
Radix Salviae Miltiorrhizae 4---20 parts in 30 parts of Radix Rehmanniae 4---30 portions of Radix Notoginseng 3---
Radix Rubiae 4---25 parts of 30 portions of Ganodermas 2---15 parts of Radix Angelicae Sinensis 3---
The Chinese medicine of this treatment liver cirrhosis is made by following method:
(1) by above-mentioned weight ratio, Radix Salviae Miltiorrhizae, the Radix Rehmanniae, Radix Rubiae, Radix Angelicae Sinensis are extracted through conventional water extraction process, make the extractum fine powder;
(2) by above-mentioned weight ratio, Radix Notoginseng, Ganoderma are ground into fine powder respectively, mix, stir with above-mentioned extractum fine powder; Make Chinese medicine granules, capsule, watered pill, Tabules.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354989A CN101843703B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating liver cirrhosis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2009102354989A CN101843703B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating liver cirrhosis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101843703A CN101843703A (en) | 2010-09-29 |
| CN101843703B true CN101843703B (en) | 2011-07-20 |
Family
ID=42768639
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2009102354989A Active CN101843703B (en) | 2009-10-16 | 2009-10-16 | Chinese medicament for treating liver cirrhosis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101843703B (en) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163776A (en) * | 1997-05-16 | 1997-11-05 | 张庆群 | Medicine for treating hepatic disease |
-
2009
- 2009-10-16 CN CN2009102354989A patent/CN101843703B/en active Active
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1163776A (en) * | 1997-05-16 | 1997-11-05 | 张庆群 | Medicine for treating hepatic disease |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101843703A (en) | 2010-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101843773B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843787B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843699B (en) | Chinese medicament for treating benign prostatic hyperplasiabrain | |
| CN101843694B (en) | Chinese medicament for treating chronic hepatitis | |
| CN102048831A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101843789B (en) | Chinese medicament for treating gout | |
| CN101850071B (en) | Chinese medicament for treating chronic nephritis | |
| CN102172369A (en) | Chinese medicine for treating hepatocirrhosis | |
| CN101843877B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843703B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101843698B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843705B (en) | Chinese medicament for treating lupus erythematosus | |
| CN101953893A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101843679B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843777B (en) | Chinese medicament for treating liver cirrhosis | |
| CN102068569A (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101843717B (en) | Chinese medicament for treating coronary disease | |
| CN101850078B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843879B (en) | Chinese medicament for treating liver cirrhosis | |
| CN101874865B (en) | Traditional Chinese medicine for treating cirrhosis | |
| CN101843844B (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101843729B (en) | Chinese medicament for treating cervical spondylosis | |
| CN101843750B (en) | Chinese medicament for treating chronic nephritis | |
| CN101843797A (en) | Chinese medicament for treating pulmonary heart diseases | |
| CN101966230A (en) | Traditional Chinese medicine for treating cirrhosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: QINGHAI-TIBET PLATEAU CHARACTERISTIC BIOLOGICAL RE Free format text: FORMER OWNER: BEIJING LVYUANQIUZHENG TECHNOLOGY DEVELOPMENT CO., LTD. Effective date: 20150428 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100040 SHIJINGSHAN, BEIJING TO: 810000 XINING, QINGHAI PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20150428 Address after: 810000 Qinghai biological science and Technology Industrial Park, Qinghai, Xining Province, No. two, No. 212, room 28 Patentee after: Qinghai Qinghai Tibet Plateau characteristic biological resources technology research and Development Co Ltd Address before: 100040 Beijing city Shijingshan District street Babaoshan Lugu Village District No. 7 building 10-602 room Patentee before: Beijing Lvyuanqiuzheng Technology Development Co., Ltd. |
|
| CP03 | Change of name, title or address | ||
| CP03 | Change of name, title or address |
Address after: 810699 building M1, No.1, South High Speed Rail Road, Pingxi Economic Zone, Haidong Industrial Park, Qinghai Province Patentee after: Qinghai Qinghai-Tibet Plateau Health Technology Co., Ltd. Address before: 810000 Qinghai biological science and Technology Industrial Park, Qinghai, Xining Province, No. two, No. 212, room 28 Patentee before: Qinghai Qinghai Tibet Plateau characteristic biological resources technology research and Development Co Ltd |